PEG — Pharma Equity A/S Cashflow Statement
0.000.00%
Last trade - 00:00- DKK96.73m
- DKK104.29m
Annual cashflow statement for Pharma Equity A/S, fiscal year end - December 31st, DKK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS/A | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 5.39 | 3.48 | -26.8 | -42.4 | -26.4 |
| Depreciation | |||||
| Non-Cash Items | -6.83 | -7.75 | 5.92 | 21.2 | 9.25 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.647 | 1.4 | 3.82 | -1.82 | -0.809 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2.09 | -2.87 | -16.6 | -22.9 | -17.7 |
| Capital Expenditures | — | — | -0.073 | 0 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | — | — | — | 0.011 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | — | -0.073 | 0 | 0.011 |
| Financing Cash Flow Items | — | — | -3.85 | -8.21 | -0.001 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.09 | 3.06 | 17.1 | 22.9 | 13.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0 | 0.182 | 0.363 | 0.003 | -3.74 |